R Cimino

836 total citations
22 papers, 531 citations indexed

About

R Cimino is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, R Cimino has authored 22 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in R Cimino's work include Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). R Cimino is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). R Cimino collaborates with scholars based in Italy, Sweden and United Kingdom. R Cimino's co-authors include Gerald Jäger, U. Essers, Gunnar Juliusson, Jerzy Hołowiecki, A Najman, Richard Greil, Diethelm Messinger, Dominique Bron, Anders Österborg and D. Peest and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Biomedicine & Pharmacotherapy.

In The Last Decade

R Cimino

22 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Cimino Italy 10 424 200 100 90 66 22 531
M. Cazzola Italy 12 639 1.5× 505 2.5× 70 0.7× 90 1.0× 50 0.8× 17 801
Eva Kabrna Austria 10 321 0.8× 151 0.8× 68 0.7× 46 0.5× 150 2.3× 13 508
Anne M. Sproul United Kingdom 11 326 0.8× 107 0.5× 98 1.0× 39 0.4× 145 2.2× 20 531
J O Moore United States 9 436 1.0× 126 0.6× 102 1.0× 13 0.1× 113 1.7× 9 600
Yeon S. Ahn United States 9 239 0.6× 57 0.3× 24 0.2× 35 0.4× 157 2.4× 10 488
Vittorio Fregoni Italy 11 173 0.4× 103 0.5× 157 1.6× 13 0.1× 32 0.5× 23 383
Gerald Jäger Austria 7 312 0.7× 239 1.2× 200 2.0× 9 0.1× 53 0.8× 8 588
S. Chèze France 12 322 0.8× 203 1.0× 53 0.5× 17 0.2× 23 0.3× 22 421
Jeffry B. Lawrence United States 10 146 0.3× 50 0.3× 58 0.6× 99 1.1× 148 2.2× 15 468
Marion Sternbach Canada 10 263 0.6× 98 0.5× 126 1.3× 8 0.1× 138 2.1× 17 529

Countries citing papers authored by R Cimino

Since Specialization
Citations

This map shows the geographic impact of R Cimino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Cimino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Cimino more than expected).

Fields of papers citing papers by R Cimino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Cimino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Cimino. The network helps show where R Cimino may publish in the future.

Co-authorship network of co-authors of R Cimino

This figure shows the co-authorship network connecting the top 25 collaborators of R Cimino. A scholar is included among the top collaborators of R Cimino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Cimino. R Cimino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noto, Rosa Di, Piernicola Boccuni, S. Costantini, et al.. (1999). In vitro exposure of acute promyelocytic leukemia cells to arsenic trioxide (As2O3) induces the solitary expression of CD66c (NCA‐50/90), a member of the CEA family. Tissue Antigens. 54(6). 597–602. 4 indexed citations
2.
3.
Ferrara, Felicetto, et al.. (1996). Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation.. PubMed. 80(5). 434–6. 4 indexed citations
4.
5.
Ferrara, Felicetto, Luigi Del Vecchio, Fabrizio Pane, et al.. (1995). Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder. American Journal of Hematology. 50(1). 49–52. 8 indexed citations
6.
Cazzola, Mario, Diethelm Messinger, Dominique Bron, et al.. (1995). Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response. Blood. 86(12). 4446–4453. 156 indexed citations
7.
Cimino, R, et al.. (1994). Early blastic transformation of a myeloproliferative disorder with t(8;21) and progressive aberrations of chromosome 8. Cancer Genetics and Cytogenetics. 75(2). 106–110. 4 indexed citations
8.
Matera, Carlo, et al.. (1994). Recombinant Interferon Alpha-2b as Treatment of Essential Thrombocythaemia. Acta Haematologica. 91(3). 126–129. 9 indexed citations
9.
Cimino, R, et al.. (1993). Recombinant interferon α‐2b in the treatment of polycythemia vera. American Journal of Hematology. 44(3). 155–157. 22 indexed citations
10.
Ferrara, Felicetto, R Cimino, Giuseppina Mele, et al.. (1992). Clinical relevance of immunological dissection in T‐ALL: A report on 20 cases with stem cell (CD7+, CD4‐, CD8‐, CD1‐) phenotype. American Journal of Hematology. 40(2). 98–102. 10 indexed citations
11.
Ferrara, Felicetto, et al.. (1992). Recombinant interferon‐α2A as maintenance treatment for patients with advanced stage chronic lymphocytic leukemia responding to chemotherapy. American Journal of Hematology. 41(1). 45–49. 14 indexed citations
12.
Ferrara, Felicetto, Giuseppina Mele, Vincenzo Mettivier, Salvatore Mirto, & R Cimino. (1992). Idarubicin as treatment for Acute Myelogenous Leukemia in the elderly. Leukemia & lymphoma. 7(sup2). 4–7. 9 indexed citations
13.
Pinto, Antonio, Vincenza Attadia, Rita Rosati, et al.. (1988). Differentiation of human leukaemic cell lines and fresh leukaemia cells by low dose Ara-C: Monitoring by expression ofc-myc andc-fos oncogenes. Medical Oncology and Tumor Pharmacotherapy. 5(2). 91–97. 3 indexed citations
14.
Ferrara, Felicetto, et al.. (1987). Immunophenotypic characterization and classification of T-acute lymphoblastic leukemia. Report of 30 cases.. PubMed. 72(3). 227–31. 4 indexed citations
15.
Pinto, Antonio, Giulia Colletta, Luigi Del Vecchio, et al.. (1987). c-fos oncogene expression in human hematopoietic malignancies is restricted to acute leukemias with monocytic phenotype and to subsets of B cell leukemias. Blood. 70(5). 1450–1457. 29 indexed citations
16.
Cimino, R, et al.. (1975). Sea-blue histiocytosis and β-thalassemia in the same family. Annals of Hematology. 30(5). 325–330. 5 indexed citations
17.
Cimino, R, et al.. (1967). Study on Nine Families with Haemoglobin Lepore in Campania. Acta Haematologica. 37(5-6). 266–275. 16 indexed citations
18.
Dini, E, et al.. (1961). [Familial Vaquez' disease].. PubMed. 52. 3236–8. 1 indexed citations
19.
Cimino, R, et al.. (1958). Resistance of Staphylococci to Antibiotics.. 33(4). 1 indexed citations
20.
Cimino, R, et al.. (1958). [In vitro results of the association of novobiocin with nine other antibiotics on 100 strains of coagulase-positive staphylococci].. PubMed. 34(11). 531–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Cazzola Breakdown of academic impact, for papers by Eva Kabrna Breakdown of academic impact, for papers by Anne M. Sproul Breakdown of academic impact, for papers by J O Moore Breakdown of academic impact, for papers by Yeon S. Ahn Breakdown of academic impact, for papers by Vittorio Fregoni Breakdown of academic impact, for papers by Gerald Jäger Breakdown of academic impact, for papers by S. Chèze Breakdown of academic impact, for papers by Jeffry B. Lawrence Breakdown of academic impact, for papers by Marion Sternbach
Rankless by CCL
2026